【Metagen, Inc.】 [Joint Research Results] Gut Microbiome Characteristics Linked to Higher COVID-19 Vaccine Antibody Levels Identified — Contributing to Understanding Individual Differences in Vaccine Response

2025.11.07

A joint research project led by the Kanagawa Institute of Industrial Science and Technology (KISTEC), in collaboration with the Kanagawa Cancer Center, Kanagawa University of Human Services, Metagen, Inc., Meiji Co., Ltd., and Meiji Holdings Co., Ltd., has revealed new insights into the relationship between the gut microbiome and COVID-19 vaccine antibody levels.

Through detailed analysis of the gut microbiome, the study identified distinct characteristics associated with individuals exhibiting higher antibody responses, contributing to a better understanding of individual variability in vaccine efficacy.

These findings were reported as part of the final results of the “Kanagawa Industry-Government-Academia Collaborative COVID-19 Antibody Survey Project.”

◆Click the link below for more details.
[Joint Research Results] Gut Microbiome Characteristics Linked to Higher COVID-19 Vaccine Antibody Levels Identified — Contributing to Understanding Individual Differences in Vaccine Response